Yunkang Group Limited

HKSE 2325.HK

Yunkang Group Limited Market Capitalization on February 07, 2025: USD 391.80 M

Yunkang Group Limited Market Capitalization is USD 391.80 M on February 07, 2025, a -54.94% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Yunkang Group Limited 52-week high Market Capitalization is USD 900.02 M on February 16, 2024, which is 129.71% above the current Market Capitalization.
  • Yunkang Group Limited 52-week low Market Capitalization is USD 384.09 M on January 27, 2025, which is -1.97% below the current Market Capitalization.
  • Yunkang Group Limited average Market Capitalization for the last 52 weeks is USD 703.49 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
SV Wall Street
HKSE: 2325.HK

Yunkang Group Limited

CEO Mr. Yong Zhang
IPO Date May 18, 2022
Location China
Headquarters No. 9 Yayingshi Road
Employees 1,459
Sector Healthcare
Industries
Description

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction and screening tests; and routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. In addition, the company offers diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; healthcare technology development; and project investment. It provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.

StockViz Staff

February 8, 2025

Any question? Send us an email